Nephrology Forum

Kidney International (1986) 30, 116–127; doi:10.1038/ki.1986.160

Extrarenal potassium homeostasis

Presentation of the Forum is made possible by grants from Sandoz, Incorporated; Merck Sharp & Dohme; and E.I. du Pont de Nemours & Company.

Principal discussant: Robert S Brown1

1Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts

Correspondence: Dr R Brown, Renal Division, Beth Israel Hospital, 330 Brookline Avenue, Boston, Massachusetts 02215, USA

Top

References

  1. Knochel JP: Potassium gradients and neuromuscular excitability, in The Kidney: Physiology and Pathophysiology, edited by Seldin DW, Giebisch G, New York, Raven Press, 1985, pp 1207–1221
  2. Epstein FH: Signs and symptoms of electrolyte disorders, in Clinical Disorders of Fluid and Electrolyte Metabolism (3rd ed), edited by Maxwell MH, Kleeman CR, New York, McGraw-Hill, 1980, pp 499–530
  3. Silva P, Brown RS, Epstein FH: Adaptation to potassium. Kidney Int 11:466–475, 1977 | ISI | ChemPort |
  4. Alexander EA, Levinsky NG: An extrarenal mechanism of potassium adaptation. J Clin Invest 47:740–748, 1968 | PubMed | ISI | ChemPort |
  5. Burnell JM, Villamil MF, Uyeno BT, Scribner BH: The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium. J Clin Invest 35:935–939, 1956
  6. Adrogué HJ, Madias NE: Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 71:456–467, 1981
  7. Perez GO, Oster JR, Vaamonde CA: Serum potassium concentration in acidemic states. Nephron 27:233–243, 1981
  8. Liebman J, Edelman IS: Interrelationship of plasma potassium concentration, plasma sodium concentration, arterial pH and total exchangeable potassium. J Clin Invest 38:2176–2188, 1959
  9. Fraley DS, Adler S: Isohydric regulation of plasma potassium by bicarbonate in the rat. Kidney Int 9:333–343, 1976
  10. Fraley DS, Adler S: Correction of hyperkalemia by bicarbonate despite constant blood pH. Kidney Int 12:354–360, 1977
  11. Rogers TA, Wachenfield AE: Effect of physiologic acids on electrolytes in rat diaphragm. Am J Physiol 193:623–626, 1958
  12. Tobin RB: Varying role of extracellular electrolytes in metabolic acidosis and alkalosis. Am J Physiol 195:685–692, 1958
  13. Oster JR, Perez GO, Vaamonde CA: Relationship between blood pH and potassium and phosphorus during acute metabolic acidosis. Am J Physiol 235:F345–F351, 1978
  14. Fulop M: Serum potassium in lactic acidosis and ketoacidosis. N Engl J Med 300:1087–1089, 1979
  15. Orringer CE, Eustace JC, Wunsch CD, Gardner LB: Natural history of lactic acidosis after grand-mal seizures. N Engl J Med 297:796–799, 1977
  16. Schwartz WB, Orning KJ, Porter R: The interned distribution of hydrogen ions with varying degrees of metabolic acidosis. J Clin Invest 36:373–382, 1957
  17. Simmons DH, Avedon M: Acid base alterations and plasma potassium concentration. Am J Physiol 197:319–326, 1959
  18. DeFronzo RA, Bia M: Extrarenal potassium homeostasis, in The Kidney: Physiology and Pathophysiology, edited by Seldin DW, Giebisch G, New York, Raven Press, 1985, pp 1179–1206
  19. Hiatt N, Yamakawa T, Davidson MB: Necessity for insulin in transfer of excess infused K to intracellular fluid. Metabolism 23:43–49, 1974 | PubMed |
  20. Hiatt N, Chapman LC, Davidson MB, Skeinkopf JA, Miller A: Inhibition of transmembrane K transfer in ureter-ligated dogs infused with KCl. Am J Physiol 231:1660–1664, 1976
  21. Pettit G, Vick RL, Swander AM: Plasma K+ and insulin: changes during KCl infusion in normal and nephrectomized dogs. Am J Physiol 228:107–109, 1975
  22. Santeusano F, Faloona G, Knochel JP, Ungar RH: Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis. J Lab Clin Med 81:809–817, 1973
  23. Dluhy RG, Axelrod L, Williams GH: Serum immunoreactive insulin and growth hormone response to potassium infusion in normal man. J Appl Physiol 33:22–26, 1972
  24. DeFronzo RA, Sherwin RS, Dillingham M, Hendler R, Tamborlane WV, Felig P: Influence of basal insulin and glucagon secretion on potassium and sodium metabolism: Studies with somatostatin in normal dogs and in normal and diabetic human beings. J Clin Invest 61:472–479, 1978
  25. DeFronzo RA, Felig P, Ferrannini E, Wahren J: Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 238:E421–E427, 1980
  26. Zierler KL: Effect of insulin on potassium efflux from rat muscle in the presence and absence of glucose. Am J Physiol 198:1066–1070, 1968
  27. Goldfarb S, Cox M, Singer I, Goldberg M: Acute hyperkalemia induced by hyperglycemia: Hormonal mechanisms. Ann Intern Med 84:426–432, 1976
  28. Ammon RA, May WS, Nightingale SD: Glucose-induced hyperkalemia with normal aldosterone levels. Ann Intern Med 89:349–351, 1978
  29. Sunderlin FS, Anderson GH, Streeten DHP, Blumenthal SA: The renin-angiotensin-aldosterone system in diabetic patients with hyperkalemia. Diabetes 30:335–340, 1981
  30. Moore RD: Effects of insulin upon ion transport. Biochem Biophys Acta 737:1–49, 1983
  31. Moore RD: Stimulation of Na:H exchange by insulin. Biophys J 33:203–210, 1981 | PubMed | ChemPort |
  32. Davis JO, Urquhart J, Higgins JT, Jr: The effects of alterations of plasma sodium and potassium concentration on aldosterone secretion. J Clin Invest 42:597–609, 1963 | PubMed | ISI | ChemPort |
  33. Boyd JP, Palmore WP, Mulrow PJ: Role of potassium in the control of aldosterone secretion in the rat. Endocrinology 88:556–565, 1971
  34. Bia M, Tyler K, DeFronzo R: Regulation of extrarenal potassium homeostasis by adrenal hormones in rats. Am J Physiol 242:F641–F644, 1982
  35. Young DB, Jackson TE: Effects of aldosterone on potassium distribution. Am J Physiol 243:R526–R530, 1982 | ISI | ChemPort |
  36. DeFronzo RA: Nephrology Forum: Hyperkalemia and hyporen-inemic hypoaldosteronism. Kidney Int 17:118–134, 1980 | PubMed | ISI | ChemPort |
  37. Lyman N, Mulgaonkar S, Walcer R, Viscuso R, Jacobs MG: Effects of mineralocorticoids on extrarenal potassium homeostasis in anuric patients. Kidney Int 23:155, 1983
  38. Charron RC, Leme CE, Wilson DR, Ing TS, Wrong OM: The effect of adrenal steroids on stool composition, as revealed by in vivo dialysis of feces. Clin Sci 37:151–167, 1969
  39. Richard P: Clinical investigation of the effects of adrenal corticosteroid excess on the colon. Lancet 1:437–441, 1969
  40. Thompson BD, Edmonds CJ: Comparison of effects of prolonged aldosterone administration on rat colon and renal electrolyte excretion. J Endocrinol 50:163–169, 1971
  41. Charney AN, Kinsey MD, Myers L, Giannella RA, Gots RE: Na-K-activated adenosine triphosphatase and intestinal electrolyte transport. J Clin Invest 56:653–660, 1975
  42. Funder JW, Feldman D, Edelman IS: Glucocorticoid receptors in rat kidney: the binding of tritiated-dexamethasone. Endocrinology 92:1005–1013, 1973
  43. Marver D Assessment of mineralocorticoid activity in rabbit colon. Am J Physiol 246:F437–F446, 1984
  44. Krozowski ZS, Funder JW: Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80:6056–6060, 1983 | PubMed | ChemPort |
  45. Quirk SJ, Gannell JE, Funder JW: Aldosterone-binding sites in pregnant and lactating rat mammary glands. Endocrinology 113:1812–1817, 1983
  46. Armanini D, Strasser T, Weber PC: Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 248:E388–390, 1985 | PubMed | ISI | ChemPort |
  47. Funder JW, Feldman D, Edelman IS: The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 92:994–1004, 1973 | PubMed | ISI | ChemPort |
  48. Simpson SAS, Tait JF: Recent progress on methods of isolation, chemistry and physiology of aldosterone. Recent Prog Horm Res 11:183–219, 1955
  49. Blair-West JR, Coghlan JP, Denton DA, Goding JR, Wright RD: The effect of aldosterone, Cortisol and corticoster-one upon the sodium and potassium content of sheep's parotid saliva. J Clin Invest 42:484–196, 1963 | PubMed | ChemPort |
  50. Emrich HM, Stall E, Rossi E: Aldosteronwirkung auf die Natriumchloridund Kalium Ausscheidung im Schweib von Pandreasfibrose-Patienten and Gesuden. Klin Wochenschr 48:966–973, 1970
  51. Silva P, Spokes K: Sympathetic system in potassium homeostasis. Am J Physiol 241:F151–F155, 1981
  52. Rosa RM, Silva P, Young JB, Landsberg L, Brown RS, Rowe JW, Epstein FH: Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 302:431–434, 1980
  53. Todd EP, Vick RL: Kalemotropic effect of epinephrine: Analysis with adrenergic agonists and antagonists. Am J Physiol 220:1963–1969, 1971
  54. Pettit GW, Vick RL: An analysis of the contribution of the exocrine pancreas to the kalemotropic actions of catecholamines. J Pharmacol Exp Ther 190:234–242, 1974
  55. Lockwood RH, Lum BKB: Effects of adrenergic agonists and antagonists on potassium metabolism. J Pharmacol Exp Ther 189:119–129, 1974
  56. Lockwood RH, Lum BKB: Effects of adrenalectomy and adrenergic antagonists on potassium metabolism. J Pharmacol Exp Ther 203:103–111, 1977
  57. Hiatt N, Chapman LW, Davidson MB: Influence of epinephrine and propranolol on membrane K transfer in anuric dogs with hyperkalemia. J Pharmacol Exp Ther 209:282–286, 1979
  58. Sterns RH, Izzo JL, Mahany D, Turgeon K: Role of the adrenergic nervous system in hyperkalemia. Kidney Int 23:267, 1983
  59. Lum BKB, Lockwood RH: Effects of nicotine and sympathomimetic amines on potassium intoxication. J Pharmacol Exp Ther 181:147–154, 1972
  60. Pedersen G, Pedersen A, Pedersen EB: Effect of propranolol on total exchangeable body potassium and total exchangeable body sodium in essential hypertension. Scand J Clin Lab Invest 39:167–170, 1979
  61. DeFronzo RA, Bia M, Birkhead G: The effect of epinephrine on potassium homeostasis. Kidney Int 20:83–91, 1981
  62. Olsson AM, Persson S, Schroder R: Effects of terbutaline and isoproterenol on hyperkalemia in nephrectomized rabbits. Scand J Urol Nephrol 12:35–38, 1978
  63. Struthers AD, Reid JL: The role of adrenal medullary catecholamines in potassium homeostasis. Clin Sci 66:377–382, 1984
  64. Berand N, Marlin GE: Characterisation of adrenoreceptor subtype mediating the metabolic actions of salbutamol. Br J Clin Pharmacol 5:207–211, 1978
  65. Brown MJ, Brown DC, Murphy MB: Hypokalemia from beta-2 receptor stimulation by circulating epinephrine. N Engl J Med 309:1414–1419, 1983
  66. Williams ME, Rosa RM, Silva P, Brown RS, Epstein FH: Impairment of extrarenal potassium disposal by alpha-adrenergic stimulation. N Engl J Med 311:145–149, 1984
  67. Carlsson E, Fellenius E, Lundborg P, Svensson L: Beta-adrenoreceptor blockers, plasma potassium, and exercise. Lancet 2:424–425, 1978
  68. Lim M, Linton RAF, Wolfe CB, Band DM: Propranolol, exercise and arterial plasma potassium. Lancet 2:591, 1981
  69. Williams ME, Gervino EV, Rosa RM, Landsberg L, Young JB, Silva P, Epstein FH: Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med 312:823–827, 1985 | PubMed | ChemPort |
  70. Clausen T, Flatman JA: The effect of catecholamines on Na-K transport and membrane potential in rat soleus muscle. J Physiol (Lond). 270:383–414, 1977 | PubMed | ChemPort |
  71. Clausen T: Adrenergic control of Na+-K+ homeostasis. Acta Med Scand (suppl) 672:111–115, 1983
  72. Flatman JA, Clausen T: Combined effects of adrenaline and insulin on active electrogenic Na+-K+ transport in rat soleus muscle. Nature 281:580–581, 1979 | Article |
  73. Hokin LE: Reconstitution of "carriers" in artificial membranes. J Membr Biol 60:77–93, 1981
  74. Landsberg L, Young JB: Fasting, feeding and regulation of the sympathetic nervous system. N Engl J Med 298:1295–1301, 1978 | PubMed | ChemPort |
  75. Rose JW, Tobin JD, Rosa RM, Andres R: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism 29:498–502, 1980
  76. Helderman JH, Elahi D, Anderson DK, Raizes GS, Tobin JD, Shocken D: Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32:106–111, 1983
  77. Akaike N, Hirata A, Kiyohara T, Oyama Y: Neural regulation on the active sodium-potassium transport in hypokalaemic rat skeletal muscles. J Physiol (Lond) 341:245–255, 1983
  78. Akaike N: Sodium pump in skeletal muscle: central nervous system-induced suppression by alpha-adrenoreceptors. Science 213:1252–1254, 1981 | PubMed | ISI | ChemPort |
  79. Valtin H: Renal dysfunction: Mechanisms involved in fluid and solute imbalance. Boston, Little, Brown, 1979, pp 89–111
  80. Welt LG, Hollander W, Jr, Blythe WB: The consequences of potassium depletion. J Chronic Dis 11:213–254, 1960
  81. Sterns RH, Feig PU, Pring M, Guzzo J, Singer I: Disposition of intravenous potassium in anuric man: A kinetic analysis. Kidney Int 15:651–660, 1979 | PubMed | ISI | ChemPort |
  82. Muggia F: Hyperkalemia and chemotherapy. Lancet 1:602–603, 1973
  83. Reza MJ, Kovick RB, Shine KI, Pearce ML: Massive intravenous digoxin overdosage. N Engl J Med 291:777–778, 1974
  84. Gronert G, Theye R: Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43:89–99, 1975
  85. Bushinsky D, Gennari F: Life-threatening hyperkalemia induced by arginine. Ann Intern Med 89:632–634, 1978 | PubMed | ISI | ChemPort |
  86. Brooks JE: Hyperkalemic periodic paralysis. Arch Neurol 20:13–18, 1969
  87. Wills MR, Fraser ID: Spurious hyperkalemia. J Clin Pathol 17:649–650, 1964
  88. Obrien TAD, Fitzgerald-Fraser J, Lewin IG, Carroll RJM: Hypokalemia due to salbutamol overdosage. Br Med J 282:1515–1516, 1981
  89. Connell JMC, Cook GM, McInnes GT: Metabolic consequences of salbutamol poisoning reversed by propranolol. Br Med J 285:779, 1982
  90. Roza O, Berman LB: The pathophysiology of barium: Hypokalemic and cardiovascular effects. J Pharmacol Exp Ther 177:433–439, 1971
  91. Zierler KL, Andres R: Movement of potassium into skeletal muscle during spontaneous attack in familial periodic paralysis. J Clin Invest 36:730–737, 1957
  92. Lawson DH, Murray RM, Parker JLW: Early mortality in the megaloblastic anemias. Q J Med (new series) 41:1–14, 1972
  93. Zierler KL, Rogus E, Hazelwood CF: Effect of insulin on potassium flux and water and electrolyte content of muscles from normal and hypophysectomized rats. Gen Physiol 49:433–456, 1966
  94. Traub YM, Rabinov M, Rosenfeld JB, Treuherz S: Elevation of serum potassium during beta blockade: Absence of relationship to the renin-aldosterone system. Clin Pharmacol Ther 28:765–768, 1980
  95. Harrington JT, Isner JM, Kassirer JP: Our national obsession with potassium. Am J Med 73:155, 1982
  96. Kassirer JP, Harrington JT: Fending off the potassium pushers. N Engl J Med 312:785–787, 1985
  97. Nordrehaug JE, Johannesen KA, von der Lippe G: Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 71:645–649, 1985
  98. Nordrehaug JE, von der Lippe G: Hypokalemia and ventricular fibrillation in acute myocardial infarction. Br Heart J 50:525–529, 1983 | PubMed | ISI | ChemPort |
  99. Nordrehaug JE, Johannesen KA, von der Lippe G, Myking OL: Circulating catecholamine and potassium concentrations early in acute myocardial effect of intervention with timolol. Am Heart J 110:944–948, 1985
  100. Adrogué HJ, Chap Z, Ishida T, Field JB: Role of the endocrine pancreas in the kalemic response to acute metabolic acidosis in conscious dogs. J Clin Invest 75:798–808, 1985
  101. Hayes CP, Jr, McLeod ME, Robinson RR: An extrarenal mechanism for the maintenance of potassium balance in severe chronic renal failure. Trans Assoc Am Physicians 80:207–216, 1967 | PubMed |
  102. Bastl CP, Hayslett JP: Augmented potassium secretion with potassium loading in aldosterone-deficient rats. Proc 7th Int Congr Nephrol Montreal, 1978, p C7
  103. Sterns RH: Oscillations of plasma K+ and insulin during K+ infusion in awake anephric dogs. Am J Physiol 243:F44–F52, 1982
  104. Pratt JH: Role of angiotensin II in potassium-mediated stimulation of aldosterone secretion in the dog. J Clin Invest 70:667–672, 1982 | PubMed | ISI | ChemPort |
  105. Textor SC, Bravo EL, Fouad FM, Tarazi RC: Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med 73:719–725, 1982
  106. Maslowski AH, Ikram H, Nicholls MG, Espiner EA: Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure. Lancet 1:71–74, 1981
  107. Parkinson CA, Belton SJ, Pratt JH: The effect of captopril treatment on potassium-induced stimulation of aldosterone production in vitro. Endocrinology 114:1567–1570, 1984

Extra navigation

.
ADVERTISEMENT